Debbie Dingell: “I commend the House for taking up this resolution raising the importance of ovarian cancer research and screening.…”

“I commend the House for taking up this resolution raising the importance of ovarian cancer research and screening. Despite the severe consequences it poses to women's health, ovarian cancer is still under-recognized and under-researched. According to the American Cancer Society, more than 23,000 new cases of ovarian cancer will be diagnosed this year alone. An estimated 13,900 women will die of ovarian cancer in 2002, accounting for more deaths than any other cancer of the female reproductive system, and ranking as the fifth leading cause of cancer deaths in women. Ovarian cancer is highly treatable when discovered in its earliest, most treatable stages. Unfortunately, it is seldom discovered until it has spread. Only 78 percent of ovarian cancer patients survive one year and just over 50 percent survive five years after diagnosis. Currently, no simple standardized tests exist to detect ovarian cancer the way mammography can reliably check for breast cancer. This is why it is essential that Congress commit itself to research in the early detection of ovarian cancer. The good news is that since 1991, the ovarian cancer incidence rate has been on the decline. The best way to ensure the continuation of these waning numbers is to invest in improved testing and research. With multiple means of early detection on the horizon, it is essential that we address this important issue as soon as possible. I urge my colleagues to join me in support of this resolution.”